Comparison of subcellular responses for the evaluation and prediction of the chemotherapeutic response to cisplatin in lung adenocarcinoma using Raman spectroscopy Haq 
Introduction
The study of the interaction of anticancer agents with cancer cell model systems is considered to be very important at the preclinical stage of the drug development 5 process in order to establish the mechanism of action of the drug as well as the response of the cell to the chemotherapeutic agent. There is great need for the development and establishment of a non-invasive analytical technique which not only can be used for the 10 analysis of the binding mechanism of the anticancer agents to their targets but which can also analyse the biological processes of the cell which occur in response to the action of the drug and ultimately predict the drug efficacy. Confocal Raman Micro spectroscopy (CRM) has emerged 15 as a viable analytical tool for the analysis of biological tissue 1 and the effect of external agents on the cell [1] [2] [3] [4] [5] . The technique is being explored extensively for the analysis of biological systems because it is non-invasive, cost effective, rapid, requires no sample labelling prior to 20 analysis and gives high content information 6 . It is capable of investigating sub-cellular biochemical structures 7, 8 and has already been explored for the analysis of the interaction of a range of chemotherapeutic agents with biological macromolecules 9 and with cancer cells 6, [10] [11] [12] . 25 In order to validate the technique of CRM for quantitative measurement of the biochemical and physiological effects of novel chemical treatments, it is necessary to demonstrate and evaluate the technique for anticancer agents whose mechanism and efficacy of action is well 30 known. The use of CRM for the analysis and prediction of the chemotherapeutic response of A549 cells to the action of the cisplatin (cis-Diamminedichloroplatinum (II)), based on analysis of the nuclear signals, has recently been demonstrated 13 . The use of both cisplatin dose, as well 35 cellular response as defined by the cytotoxicity assay, MTT, as targets for PLS regression enabled a differentiation between the spectral changes associated with the direct chemical interaction with the nucleus and the resultant metabolic response. 40 It is also of great importance to understand and characterize the biochemical changes in the membrane and cytoplasm of cells during the course of the action of chemotherapeutic agents. These can occur due to the primary interactions during uptake of the agent, but also as 45 a result of the subsequent cellular response. Cisplatin is widely used to treat a variety of cancers including lung, ovarian, colon, cervical, bladder, head and neck and testicular cancers, either as an individual agent or in combination with other drugs [14] [15] [16] [17] . Its mechanism of 50 chemical interaction is well characterised. While entering the cell, cisplatin interacts with lipids of the cell membrane which may affect the function of the cell membrane 18 , while inside the cytoplasm, it may bind to RNA and thiol groups of peptides and proteins 19 . In the cytosol, binding 55 of cisplatin with some proteins may lead to the development of cytoxicity and resistance
20
. In the nucleus, it binds with DNA forming inter-strand and intra-strand crosslinks which lead to cell cycle arrest and apoptosis, the primary cytotoxicological response 21 .
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In the current study, the capabilities of CRM for the elucidation of the mechanism and efficacy of chemotherapeutic agents are further evaluated by exploring the spectral changes in the cell membrane and cytoplasm, using cisplatin and A549 adenocarcinoma cells as a model 65 compound and test system respectively. Spectra of the cell membrane and cytoplasm of A549 cells were taken after a 96 hour exposure period to the agent, and multivariate models of the variation in spectral content with levels of exposure and degrees of cytotoxicological response, as 70 determined by the MTT assay were constructed. A feature selection technique was then used to identify regions of the spectrum that were associated with the biochemical effect of exposure to the agent, and with the subsequent cytotoxicological response of the cells. with all the supplements as listed above. After 24 hrs of initial cell attachment, the plates were washed with 100 µl/well phosphate buffered saline (PBS) and were treated with varying concentrations of cisplatin in the range from 0.05 µM-50µM (including a separate unexposed control 10 sample). Following a 96-hour exposure period, the cells were rinsed with PBS and 100 µl of fresh medium (without supplements) were added to each well. A volume of 10 µl of MTT (5mg/ml) prepared in PBS was then added to each well and the plates were incubated for 3 hrs at 37 °C in a 15 5% CO 2 humidified incubator. After this incubation period, the medium was discarded, the cells were washed with 100 µl of PBS and 100 µl of DMSO was added to each well to extract the dye. The plates were then shaken 240 times per minute for 10 min and the absorbance was measured at 570 20 nm using a micro plate reader (Tecan Genios, Grodig, Austria). Six replicate wells were used for each exposure.
Protein extraction
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The cellular protein was extracted from both a control sample of A549 cells together with a sample of A549 cells exposed to 3 µM cisplatin for 96 hours. The 3 µM exposure level was chosen as it provided the means to examine the ability of CRM to identify relatively small 30 levels of changes in protein, structural and conformational, as a result of cisplatin binding. As determined using the cytotoxicity assay, at this concentration, the viability has reduced to approximately 30% and thus it represents the inverse exponential point of the response. Briefly, cells 35 were trypsinised and centrifuged to form a pellet of cells, and 1 ml TRIzol reagent (Invitrogen) per 5 -10 × 10 6 cells was added. The samples were then homogenized and incubated at room temperature for 5 min to induce cell lysis. For each ml of TRIzol reagent, 200 µl of chloroform 40 was added and samples were centrifuged at 12,000 × g for 5 min at 4 °C. Following centrifugation, the mixture separated out into a lower red organic phase, a thin interphase and a colourless upper aqueous phase. Then 300 µl of 100% ethanol per ml of TRIzol reagent was added to 45 the interphase and organic phase followed by mixing and spinning which yielded a pellet and supernatant. The supernatant was used to extract the proteins. To precipitate proteins, 1.5ml of isopropanol/ml of Trizol reagent used was added for initial homogenization. The samples were 50 stored at room temperature for 10 minutes and sedimented by centrifugation at 12000xg for 10 min. and 4 °C. The supernatant was removed and the protein pellet was washed three times with 0.2M guanidine thiocyanate to remove phenol and dye. After the final wash, the protein 55 pellet was vortexed in 2 ml 100% ethanol and was stored in ethanol for 20 minutes at room temperature. After that, the pellet was air dried and dissolved in 1% SDS (Sodium Dodecyl Sulphate) and then incubated at 50 °C, to extract the proteins from the pellet. The insoluble material was 60 sedimented by centrifugation at 10,000 g for 10 min. at 4 °C and the supernatant containing total cellular proteins was transferred into a clean tube. To get the proteins in pellet form from this supernatant, acetone precipitation of the proteins was performed. To do this, equal volumes of 65 the ice-cold acetone was added to the protein supernatant and incubated on ice for 15 minutes followed by the centrifugation for 10 min. at 12000 x g in a pre-cooled microcentrifuge at 4 ë. The supernatant was discarded and pellet was air dried. In order to verify the purity of the 70 proteins, the absorbance of the sample was recorded on a UV-Vis spectrophotometer at 260nm and 280nm. A ratio of 0.6 (A260/A280) is characteristic of pure protein. The pellet was dissolved in dH 2 O, as water has a significantly weaker Raman signal than common organic solvents, and 75 was used immediately for analysis by Raman spectroscopy.
Sample preparation for Confocal Raman Spectroscopy
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For CRM, cell samples were cultured on quartz substrates according to a protocol outlined elsewhere 1 . Briefly, quartz coverslips were coated with a 2% w/v gelatin-water solution and maintained at 4 °C for 6 hrs to allow polymerization of the gelatin to the substrate. 85 Subsequently, 2.5 × 10 3 A549 cells were attached to the substrates for a 48 hour period, and were exposed to the cisplatin concentrations in the range 0.05 µM-50µM for a 96-hour period (together with a non-exposed control sample). After the exposure period, the cells were fixed in 90 4% formalin for 10 minutes and were stored in 0.9 % physiological saline solution at 4 °C until the Raman analysis was performed 5 . Fixing the cells allows prolonged periods of storage and measurement. In a previous study, it has been demonstrated that although all 95 commonly employed fixatives result in some degree of nucleic acid degradation, protein denaturation, and lipid leaching, fixing in formalin, in comparison to other fixatives, best preserves the integrity of the cells compared to live cells. 5 All samples were prepared in triplicate.
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Spectral Acquisition
CRM was conducted with a Horiba Jobin-Yvon, LabRam HR800 instrument using a 785 nm laser as source. The 105 laser power was approximately 70 mW at the sample. Spectra were taken in the range from 600 cm -1 to 1800 cm -1 with a confocal hole diameter of 100µm. A ×100 water immersion objective was used to focus the laser on the sample, immersed in 0.9% saline. The spatial resolution of 110 the instrument has previously been checked by performing a linescan of 1µm Iron oxide particles with a 0.2 µm step size, which produced a profile of 1.5µm FWHM, implying a spotsize of 1.12µm 7 .Multiple spectra were recorded from the cell membrane and cytoplasm portion and nucleus for a 115 previously reported study 13 of a total of 60 cells at each cisplatin exposure level, by performing a line scan across each cell as illustrated in Figure 1 (a). Each scan was set up by initially focussing on the nucleus of the cell. Subsequently, the spectra were filtered with a SavitskyGolay filter (order 5, 13 point window), and the quartz 5 signal background was subtracted using algorithms developed in-house. Prior to analysis, the spectra were also vector normalized. For the acquisition of the spectra from the extracted protein, the protein dissolved in water was drop cast onto quartz substrates immediately prior to 10 measurement.
Data analysis
All spectral analysis was performed in the Matlab 7.2 (The Mathworks Inc.) environment employing the PLS Toolbox 15 5.0.3 (Eigenvector Research, Wenatchee, WA) and algorithms developed in-house. Outlying spectra were removed using Grubb's filtering 23 . All spectra, including calibration and substrate backgrounds, were vector normalized. The substrate spectra were subtracted from 20 each spectrum and a fifth order polynomial was fitted to and subtracted from the spectra to remove any residual spectral baseline. Multivariate regression models were constructed using Partial Least Squares Regression (PLSR) 24 and PLS Jack-knifing was employed as a multivariate 25 feature selection technique [25] [26] [27] . The PLSR algorithm seeks to develop a model that relates the spectral data (X-matrix) to a series of targets (Y-matrix, e.g. concentration of reaction product or analyte) according to the equation Y=XB+E, where B is a matrix of regression coefficients 30 and E is the regression residual. The Y-matrix here consisted of values of the concentration of cisplatin to which the cell was exposed, or the measured level of cell viability from the MTT assay. The PLS Jack-knifing method developed by Martens and colleagues was then 35 used to determine the spectral features that were statistically significant at a particular level of confidence using t-testing of the regression coefficients, B. 27 . The Raman band assignments used in interpretation of the spectral features were taken from the literature [28] [29] [30] [31] [32] .
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Results and Discussion
Comparison of the mean control spectra of the cell membrane, cytoplasm and nucleus 45 The mean control spectra of the cell membrane, cytoplasm and nucleus of A549 cells are shown in Figure 1(b) . The mean control spectra of all the three cellular components appear similar to the naked eye. In a similar analysis of 50 live cells using K-means clustering, the nuclei, cytoplasm and membrane were clearly differentiated and spatially located, but the average K-cluster spectra showed similarly few identifiable spectral differences 7 . This is perhaps not surprising as, with a 1µm spot size, the nucleus can be 55 specifically targeted, but the overlying cellular membrane and cytoplasm will also contribute to the spectrum acquired. Similarly, the spectrum of the cytoplasm will contain contributions from the overlying cellular membrane and potentially also from subcellular organelles 60 such as mitochondria, lysosomes, etc., and inevitably the spectra of the cell membrance will contain contributions from the neighbouring cytoplasm. Careful analysis of the spectra reveals however some differences which distinguish the spectra of the cell 65 membrane and cytoplasm from the nucleus as demonstrated by the scatter plot of the Principal Component Analysis (PCA) shown in Figure 2(a) . There is very good separation indicating that the spectra for the three cellular components are different and these 70 experimental settings can be used for acquiring reliable spectra from the samples. The cellular regions are effectively separated according to PC1 which accounts for 95.58% of the variance and the spectral loadings are illustrated in Figure 2 , which can be assigned to tryptophan and/or CH 3 80 stretching of the lipids, is present in the cytoplasm and cell membrane spectra but is not prominent in the nuclear spectra. The Raman band at 1423 cm -1 is assigned to CH 3 deformation of aromatic lipids and is present in the spectra of the cell membrane and cytoplasm but is similarly not ). Due to the action of the cisplatin, changes in these bands are also expected. 95 For the nuclear mean spectra, the important Raman peaks which are different from the spectra of the cytoplasm and cell membrane are labelled. The Raman band at 718 cm assigned to the O-P-O stretching of the DNA backbone in general. These three Raman markers of the DNA backbone are present in the spectra of the nucleus with much higher intensity as compared to the spectra of the cytoplasm and 105 membrane. The Raman bands at 669 cm -1 (Thymine) and 1336 cm -1 (Guanine) are present, both in the mean spectra of the nucleus and cytoplasm which is expected, as their presence in the cytoplasm may be due to cytoplasmic DNA, and are unexpectedly seen in the membrane spectra 110 which may be the contribution from the surrounding cytoplasm 29 . Comparing the mean control spectra of the nucleus of A549 cells with that of the cell membrane and cytoplasm, ideally, there should be no peaks in the nuclear spectra for may be due to the contribution from the surrounding cytoplasm 33 and 29 or on the other hand this band can be assigned, both to lipids and proteins 34 .
Cytotoxicity of cisplatin
5
The dose response curve representing the cytotoxic response of cisplatin to A549 cells after 96 hrs is presented in Figure 3 (reproduced from results published elsewhere) 13 , where the level of viability in each sample 10 was normalised to that in the control sample. Due to the action of the drug, the mitochondrial activity decreases monotonically which in turn leads to a decrease in cell viability. Effect of cisplatin exposure on the spectra of cell membrane Figure 4 shows the mean control (A) and difference 30 spectrum of the cell membrane (B) of A549 cells exposed to 3 µM cisplatin versus its control. It should be noted that no significant contributions due to the cisplatin itself are expected, as its Raman spectrum is dominated by bands in the region between 100-550 cm -1 (Nawaz et al., 2010), 35 which does not fall within the 600-1800 cm -1 spectral window of the current measurements. The most prominent changes are observed in the bands related to proteins at 671 cm -1 and 728 cm -1 (ring breathing of the tryptophan), 1030cm -1 (C-H bending), 1094 cm -1 and 1126 cm -1 (C-N 40 stretching) and 1655 cm -1 (amide-I). In addition to this, shifts in some of the Raman bands are also observed, including 1094 to 1097 cm -1 and 1126 to 1129 cm -1 (C-N stretching) and 1655-1659 cm -1 (amide-I) as labelled in the mean difference spectra. 45 The Raman bands at 1371 cm -1 (CH 3 stretching) and 1448 cm -1 (CH deformation), related to cell membrane lipids, also undergo shifts from 1371 to 1376 cm -1 and 1448 to 1450 cm -1 . These spectral changes and shifts in the Raman signatures of the membrane proteins and lipids are 50 consistent with the well known direct interaction of cisplatin 37 and may also provide indications of the indirect action of the agent on cellular function 18 .
Mean control and difference spectra of the cytoplasm
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The mean control and difference spectra of the cytoplasm 85 of A549 cells exposed to 3 µM cisplatin are shown in Figure 5 A and B respectively. The bands in which the major changes are observed are related to proteins, and include 671 cm 
Spectra of extracted protein
In order to further confirm the Raman markers for the 105 direct chemical action of cisplatin and the cytotoxic response of the A549 cells to the cisplatin exposure from the cell membrane and cytoplasm, the spectra recorded of the protein extracted from the control and exposed (3 µM for comparison to the spectroscopic analyses of the cells) 110 A549 cells were analyzed. The mean control and the difference spectra of the extracted protein are shown in ). It should be noted that the extract does not differentiate between membrane and cytoplasmic proteins and that the in situ cellular environment is very different from that of 10 the ex situ dried state, and thus that the spectral changes of figure 6 cannot be quantitatively compared to those observed in the cells. Nevertheless, the spectral changes in the protein extracted from cisplatin exposed compared to control cell cultures confirms a significant modification of 15 the protein structure as a result of the exposure, by direct or indirect means. Normally, in a cell, proteins are folded in a well-ordered structure and the side chains of the proteins are constrained 34 and thus the intensities of these Raman bands are suppressed in the spectrum of the control 20 as compared to the exposed. The increase in the intensities of these bands may be due to the direct binding of the cisplatin to the associated proteins which causes changes in their secondary structure and causes their unfolding, exposing the phenylalanine/tyrosine/tryptophan side ), are also observed. These two Raman bands are frequently used to allocate secondary structure to the proteins 38 and the shifts observed in these bands can be the Raman markers of the conformational changes in the associated 35 proteins as a result of the action of the cisplatin. The changes observed in the Raman spectra of the extracted proteins can also be identified in the mean control and difference spectra of the cell membrane or cytoplasm or both albeit with slight deviations of their For a fixed exposure concentration, the analysis of the mean difference spectra for cytoplasm and cellular membrane highlight the effects of the cellular interaction with the cellular structures which can be the result of the 55 direct chemical interaction of the agent or the resulting physiological (cytotoxic response). The former should be correlated with the applied dose, whereas the latter should be correlated with the physiological response (Figure 3) . In an attempt to differentiate the responses, the spectral 60 data, for each cellular region, over the whole exposure range, were subjected to a multivariate Partial Least Squares Regression (PLSR), using the chemical concentration and cytotoxicological response, respectively. The PLS Jack-knifing procedure was furthermore 65 employed to identify the spectral features of maximum variance as a function of the respective parameters. The regression co-efficients obtained by PLS-Jack knifing for the cell membrane data, regressed against cisplatin concentration (Figure 7 A) , (C-H deformation) to 1466 cm -1 is observed in the mean difference spectra, (Figure 3 B) , On the basis of 80 the information derived, it seems that cisplatin interacts with the membrane lipids and causes some changes in their structure. It has been reported by 37 that cisplatin interacts with the membrane lipids which can cause neurotoxicity and that this interaction with the lipid bilayer can cause an , 903-923 cm -1 , 928-931 cm -1 , (C-C skeletal stretching), 958-987 cm -1 (C-C skeletal β-sheets) which may be due to the membrane protein signalling as a result of the attack and action of the cisplatin on the cell membrane.
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Feature Selection by PLS Jack-knifing for the data from Cytoplasm
For the cytoplasm data, the regression co-efficients 115 obtained by PLS-Jack knifing, are shown, for regression against cisplatin concentrations (Figure 8 A) and against cell viability (Figure 8 B) .
As a result of the chemical effect (Figure 8 A) , features primarily related to proteins are identified. In addition to the observations of the same Raman bands for proteins as observed in the mean difference spectra (Figure 4 B) , Jack 5 knifing results for cytoplasm data show that there is a positive shift of the amide I band from 1664 cm -1 to 1676 cm -1 with increasing cisplatin concentration, which may be indicative of the changes in the secondary and tertiary structure of the protein. 10 The regression against the cell viability (Figure 8 B) shows features related to the change in the cell physiology due to the action of the cisplatin and include tryptophan ring breathing (714-715 cm -1 , 724-727 cm ). 30 CRM can clearly fingerprint the effects of the interaction of the chemotherapeutic agent within the cellular regions and identify that fingerprint within the cellular spectra of exposed cells. PLSR models of A549 cellular membrane 35 and cytoplasmic spectra versus concentration and viability measurements from the MTT assay were constructed to determine the ability of the Raman spectral data to predict the level of exposure to cisplatin and the resultant physiological effect. 40 For the construction of the PLSR model, all spectra of each cellular region were compiled into a matrix, and were randomly sorted. A total of 60% of the spectra were used to train the PLSR regression model and 40% of the total was retained as an independent test set to assess the 45 performance of the model in predicting the level of exposure, and the cellular viability, with unseen data. Leave-one out cross validation with the calibration set was used to determine the optimal model complexity for use in testing 26 . This process was performed on fifty separate 50 occasions, with randomization of the data matrix and splitting of the data on each occasion to prevent data bias 24 . The reliability/uncertainty of the model can be determined from the results from the values of the root mean square error of calibration (RMSEC) and the root 55 mean square error of prediction (RMSEP). Control of overfitting was achieved using a procedure previously described by Martens and Naes 39 . The procedure involves selection of the optimal number of latent variables to retain within the PLS model via ten-fold cross-validation with the 60 calibration data set. The optimal number of LV's was then selected on the basis of the number which provided the lowest root mean squared error at cross validation. An example of the results of the PLSR model prediction of the cellular viability for the cell membrane data is shown 65 in Figure 9 , where the values of the root mean square error of calibration (RMSEC) and the root mean square error of prediction (RMSEP) denote the prediction uncertainty. The mean values of the RMSEC and RMSEP for the PLSR for prediction of the level of exposure to cisplatin (from the 70 spectra of cell membrane) were found to be 3.01 µM and 4.74 µM respectively. The associated values of RMSEC and RMSEP for PLSR against normalized cellular viability were 0.06 and 0.12 respectively. The RMSEP for prediction of cisplatin concentration is therefore 9.48% 75 over the full scale range (0 to 50 µM), and 12% over the full scale range of viability (from 0 to 1).
PLS-model for the prediction of levels of the exposures and cellular viability
The mean values of the RMSEC and RMSEP for the PLSR for prediction of the level of exposure to cisplatin (from the spectra of cytoplasm) were found to be 1.47 µM and 80 3.74 µM respectively. The associated values of RMSEC and RMSEP for PLSR against normalized cellular viability were 0.07 and 0.14 respectively. The RMSEP for prediction of cisplatin concentration is therefore 7.48% over the full scale range (0 to 50 µM), and 14% over the 85 full scale range of viability (from 0 to 1).
In the previous study of the nuclear spectra of the same system, the mean values of the RMSEC and RMSEP for the PLSR for prediction of the level of exposure to cisplatin were found to be 1.67 µM and 3.41 µM accuracy is found for regression against the cisplatin dose, and for both regression against dose and physiological response, nuclear data yields higher precision. As cisplatin primarily interacts with DNA in the nucleus, 5 the largest effects of the agent are manifest there, either due to the direct chemical interaction of the drug or due to the physiological response of the cell to it. This may be the reason why the PLSR model gives the highest prediction accuracies for both the level of exposure and cell viability, 10 for the nuclear data. It should further be noted that PLSR is a linear model, and is thus limited for a nonlinear response. In operational models of pharmacological agonism, the relationship between the agonist concentration and that of receptors 15 occupied by the agonist is in itself a hyperbolic function 40 and thus it may be expected that the direct chemical effect as a result of the interaction of cisplatin with nuclear DNA or other subcellular molecular components, as monitored 20 by Raman spectroscopy is not a linear function. The dependence of the physiological effects on the agonist concentration is a further complex function, as a result of the ensuing biochemical cascades, but is generally described by the operational equation employed to fit the 25 cytotoxicity data of Figure 3 . It may be expected therefore that a regression of the spectral data against the physiological effect as expressed by the cell viability should yield a more precise result. However, it has been demonstrated for the case of low dose radiation responses 30 in cellular systems, that the spectral responses are not linearly dependent on the physiological responses as measured by cytoxicological assays 41 Furthermore, it may be expected that the cascade of biochemical process introduces an increasing degree of variability into the 35 measured response. In the development of spectroscopic cytological assays is crucial. Ultimately, a more flexible nonlinear model is desirable, whereby the spectral data can be regressed against a user definable function. The results demonstrate Raman spectroscopy is a powerful tool to explore the molecular basis of the action of 105 chemotherapeutic agents in vitro. As well as elucidating the mechanisms of interaction, the regression models can be employed in a predictive capacity. These findings also suggest that the technique should be applied to the spectral data from each component of the cell separately 110 in order to increase the accuracy in the prediction of level of exposure and viability of the cell on the basis of the spectral changes. It should be noted that the cell 
